We use first- and third-party cookies to provide our services and collect statistical data. By continuing to browse you accept these cookies. More information Accept
CNS SPECIALIST /DEVELOPMENT & MANUFACTURING /APIs – INKE
ACTIVE PHARMACEUTICAL INGREDIENTS (APIs)

ACTIVE PHARMACEUTICAL INGREDIENTS (APIs)

Inke, Neuraxpharm's APIs manufacturing plant, is a developer and manufacturer of high‐added value active substances for
the pharmaceutical industry 
for use in respiratory and CNS therapies

INKE IS A KEY SUPPLIER TO MAJOR GENERIC AND BRANDED COMPANIES WORLDWIDE

APIs manufacturing plant
active substances for the pharmaceutical industry
CNS therapies

HIGHEST QUALITY APIs WITH COMPLEX SYNTHESIS PROCESSES

Inke has been developing, patenting and implementing its own synthetic routes and polymorphs for the manufacture of active pharmaceutical ingredients since 1980
  • respiratory and CNS therapies

    High‐added value active substances with complex synthesis processes, mainly for use in respiratory and CNS therapies

  • micronisation technology

    Over 20 years' experience in in-house micronisation technology

  • active pharmaceutical ingredients since 1980 Worldwide strong reputation and brand image
  • Neuraxpharm certifications Certifications: EU-GMP, last FDA inspection April 2016, ISO 9001, ISO 14001, Certificates of Suitability (CEPs).
    Policies: Quality, HSE
  • customising products (PSDs)

    Expert in customising products (PSDs) to meet each client's technical and regulatory
    needs

  • respiratory APIs Quality‐based but competitive philosophy to establish and develop stable collaborations with leading companies in Europe, the US, Japan, Korea and China

HIGH-ADDED VALUE ACTIVE SUBSTANCES FOR USE IN RESPIRATORY THERAPIES

Given the stringent requirements for inhalators, the high level of its technical and regulatory standards makes Inke a leading manufacturer in respiratory APIs


Multipurpose plant designed to meet the stringent standards required for parenteral grade and respiratory products

LEARN MORE ABOUT INKE